Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Verbio SE manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently features 1 pending office action. This prosecution is being conducted by a lone distinct examiner and is situated within a lone distinct art unit. This suggests a very specific technical focus for the company's current active patent filings. The Biotechnology & Pharmaceuticals focus indicates that the company is likely developing innovations in the field of bioenergy or pharmaceutical processes.
The busiest examiner for Verbio SE is PAGANO, ALEXANDER R, who is responsible for 1 busiest examiner pending office action. This accounts for the entirety of the company's pending office actions. For practitioners, this means that the prosecution outcome is highly dependent on this examiner's review. The presence of a lone distinct examiner and a lone distinct art unit indicates that the company's current active intellectual property is focused on a specific area, making the successful resolution of this 1 pending office action a primary goal for the company's biotechnology portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAGANO, ALEXANDER R | 1 | 78.7% | +11.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17999197 | AIR-STABLE IMIDO ALKYLIDENE COMPLEXES AND USE THEREOF IN OLEFIN METATHESIS REACTIONS | PAGANO, ALEXANDER R | 61d |
| Art Unit | Apps |
|---|---|
| 1692 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17999197 | AIR-STABLE IMIDO ALKYLIDENE COMPLEXES AND USE THEREOF IN OLEFIN METATHESIS REACTIONS | PAGANO, ALEXANDER R | 1692 | §112DPOther | Final Rejection | 61d | Pending | Nov 17, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial